Pharmaceutical Patent Issues: Interpreting GATT : Hearings Before the Committee on the Judiciary, United States Senate, One Hundred Fourth Congress, Second Session ... S. 1277, a Bill to Provide Equitable Relief for the Generic Drug Industry, and for Other Purposes, February 27, and March 5, 1996, 4. sējumsU.S. Government Printing Office, 1997 - 291 lappuses |
Citi izdevumi - Skatīt visu
Bieži izmantoti vārdi un frāzes
American ANDA benefits bill biotechnology brand companies Bristol-Myers Squibb captopril ceutical CHAIRMAN Committee Congress consumers cost Delta period district court dollars drug application drug companies drug industry drug manufacturers drug patent Drug Price Competition effective enacted equitable remuneration FDA approval February 13 Federal filing Flolan Food and Drug GATT Glaxo Grabowski granted Hatch-Waxman Act implementing incentives innovation intellectual property issue KANTOR legislation Medicaid ment million MOSSINGHOFF neric paragraph IV certification patent expiration dates patent extension patent holder patent law patent protection patent term extension Patent Term Restoration percent pharma pharmaceutical industry pharmaceutical patents pioneer drug Premarin prescription drugs property rights research and development Round Agreements Act Royce Royce's Senator FEINSTEIN Senator Pryor submitted substantial investment term of patents Term Restoration Act tion transition rules transitional provision U.S. patent U.S. Senate U.S. Trade Representative United URAA Uruguay Round Agreements Waxman windfall Zantac
Populāri fragmenti
81. lappuse - RNA, hybridoma technology, or other processes involving site specific genetic manipulation techniques) solely for uses reasonably related to the development and submission of information under a Federal law which regulates the manufacture, use, or sale of drugs or veterinary biological products.
63. lappuse - ... to those who entitle themselves to such grants. The Government of the United States, as well as the citizen, is subject to the Constitution; and when it grants a patent the grantee is entitled to it as a matter' of right, and does not receive it, as was originally supposed to be the case in England, as a matter of grace and favor.
255. lappuse - Upon finding for the claimant the court shall award the claimant damages adequate to compensate for the infringement but in no event less than a reasonable royalty for the use made of the invention by the infringer, together with interest and costs as fixed by the court.
61. lappuse - ... personal" right, whether the "property" in question be a welfare check, a home, or a savings account. In fact, a fundamental interdependence exists between the personal right to liberty and the personal right in property. Neither could have meaning without the other.
240. lappuse - ... the forms of law and the machinery of government, with all their reach and power, must in their actual workings stop on the hither side of the unnecessary and uncompensated taking or destruction of any private property, legally acquired and legally held.
81. lappuse - Except as otherwise provided in this title, whoever without authority makes, uses, offers to sell or sells any patented invention, within the United States or imports into the United States any patented invention during the term of the patent therefor, infringes the patent.
58. lappuse - Such difficulties indicate that the dichotomy between personal liberties and property rights is a false one. Property does not have rights. People have rights. The right to enjoy property without unlawful deprivation, no less than the right to speak or the right to travel, is, in truth a "personal" right, whether the "property" in question be a welfare check, a home or a savings account.
245. lappuse - ... the powers of Congress to legislate upon the subject of patents is plenary by the terms of the Constitution, and as there are no restraints on its exercise, there can be no limitation of their right to modify them at their pleasure, so that they do not take away the rights of property in existing patents.
242. lappuse - ... the right to exclude others from making, using, offering for sale, or selling the invention throughout the United States or importing the invention into the United States, and, if the invention is a process, of the right to exclude others from using, offering for sale or selling...
245. lappuse - ... to exclude others from making, using, offering for sale, or selling the invention throughout the United States or importing the invention into the United States, and, if the invention is a process, of the right to exclude others from using, offering for sale or selling throughout the United States, or importing into the United States, products made by that process, referring to the specification for the particulars thereof.